RPL23AP84

Across TCGA pan-cancer cohorts, RPL23AP84 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL23AP84’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RPL23AP84 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL23AP84 is over-expressed in tumor.

STAD and HNSC are the cancer types where RPL23AP84 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL23AP84 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	+0.039	.023	2	view →
HNSC	All	II,III,IV	+0.017	.047	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RPL23AP84–STAD

Open the STAD breakdown →